All Stories

  1. Calcium-Sensing Receptor as a Novel Target for the Treatment of Idiopathic Pulmonary Fibrosis
  2. Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial
  3. Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era?
  4. Platelets Independently Recruit into Asthmatic Lungs and Models of Allergic Inflammation via CCR3
  5. Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome
  6. <p>Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?</p>
  7. Why inhalers are helpful to control asthma and COPD.
  8. Prevalence, determinants and clinical correlates of vitamin D deficiency in adults with inhaled corticosteroid-treated asthma in London, UK
  9. Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK
  10. Characteristics of Proinflammatory Cytokines and Chemokines in Airways of Asthmatics
  11. Cigarette smoking increases bronchial mucosal IL‐17A expression in asthmatics, which acts in concert with environmental aeroallergens to engender neutrophilic inflammation
  12. Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling
  13. AllergoOncology – the impact of allergy in oncology: EAACI position paper
  14. Azithromycin for Acute Exacerbations of Asthma
  15. Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)
  16. Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes
  17. Urban Particulate Matter–Activated Human Dendritic Cells Induce the Expansion of Potent Inflammatory Th1, Th2, and Th17 Effector Cells
  18. Inhaled corticosteroid dose-response on blood eosinophils in asthma – Authors' reply
  19. Farewell
  20. The Editor takes a closer look at some of this month's articles
  21. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
  22. Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol
  23. Analysis of a Panel of 48 Cytokines in BAL Fluids Specifically Identifies IL-8 Levels as the Only Cytokine that Distinguishes Controlled Asthma from Uncontrolled Asthma, and Correlates Inversely with FEV1
  24. Calcium-sensing receptor antagonists abrogate airway hyperresponsiveness and inflammation in allergic asthma
  25. Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma: from mouse to man
  26. Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33
  27. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3supplementation in adults with asthma (ViDiAs)
  28. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial
  29. “Auto-anti-IgE”: Naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation
  30. Imaging Inflammation in Asthma: Real Time, Differential Tracking of Human Neutrophil and Eosinophil Migration in Allergen Challenged, Atopic Asthmatics in Vivo
  31. Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells
  32. Poster Session Group I
  33. The effects of calcitriol treatment in glucocorticoid-resistant asthma
  34. Direct comparison of the dynamics of IL-25- and ‘allergen’-induced airways inflammation, remodelling and hypersensitivity in a murine asthma model
  35. Real-time differential tracking of human neutrophil and eosinophil migration in vivo
  36. CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4
  37. Epidemiological associations of allergy, IgE and cancer
  38. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion
  39. Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma
  40. Beurteilung der Wirksamkeit der spezifischen Immuntherapie anhand einer neuartigen Methode auf der Basis des Plazebo-Scores
  41. Inhaler devices – From theory to practice
  42. Assessment of specific immunotherapy efficacy using a novel placebo score–based method
  43. Interleukin‐25 promotes basic fibroblast growth factor expression by human endothelial cells through interaction with IL‐17RB, but not IL‐17RA
  44. Serum 25-dihydroxyvitamin D levels correlate with CD4+Foxp3+ T-cell numbers in moderate/severe asthma
  45. T cells producing the anti-inflammatory cytokine IL-10 regulate allergen-specific Th2 responses in human airways
  46. Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma
  47. Special issue on severe asthma
  48. Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application
  49. Lung Homing of Endothelial Progenitor Cells in Humans with Asthma after Allergen Challenge
  50. Identifying and testing potential new anti-asthma agents
  51. Immunotherapy for allergic rhinitis
  52. Resistin-like molecule-β is a human airway remodelling mediator
  53. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses
  54. Retail sales of inhalation devices in European countries: So much for a global policy
  55. Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI‐mediated basophil activation by a tumour‐specific IgE antibody to evaluate the risk of type I hypersensitivity
  56. T-helper cell type 2 (Th2) memory T cell-potentiating cytokine IL-25 has the potential to promote angiogenesis in asthma
  57. A novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity
  58. The Role of Thymic Stromal Lymphopoietin in Allergic Inflammation and Chronic Obstructive Pulmonary Disease
  59. IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
  60. Diminished sarco/endoplasmic reticulum Ca2+ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma
  61. Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen‐induced late phase cutaneous responses in atopic subjects
  62. Counter regulation of the high affinity IgE receptor, FcεRI, on human airway dendritic cells by IL-4 and IL-10
  63. Ligation of TLR9 induced on human IL-10–secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory function
  64. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD
  65. Role of cysteinyl leukotrienes in human allergen-specific Th2 responses induced by granulocyte macrophage-colony stimulating factor
  66. Effect of grass pollen immunotherapy with Alutard SQ® on quality of life in seasonal allergic rhinoconjunctivitis
  67. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cells
  68. Increased prevalence of gastrointestinal symptoms in patients with allergic disease
  69. Sublingual immunotherapy
  70. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma
  71. Lack of filaggrin expression in the human bronchial mucosa
  72. Germinal-centre reactions in allergic inflammation
  73. Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients
  74. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells
  75. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis
  76. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients
  77. Eph and NMDA receptors control Ca2+/calmodulin-dependent protein kinase II activation duringC. elegansoocyte meiotic maturation
  78. Functional plasticity of human respiratory tract dendritic cells: GM-CSF enhances TH2 development
  79. IL-4–expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR3 and CCR4
  80. Interleukin-10–Secreting “Regulatory” T Cells Induced by Glucocorticoids and β2-Agonists
  81. Methotrexate therapy of oral corticosteroid‐dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy
  82. Efficacy and safety of preseasonal‐specific immunotherapy with an aluminium‐adsorbed six‐grass pollen allergoid
  83. Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis
  84. Glucocorticoid Action and Resistance in Asthma
  85. Expression of prostaglandin E2 receptor subtypes on cells in sputum from patients with asthma and controls: Effect of allergen inhalational challenge
  86. Mechanisms of intrinsic asthma
  87. Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition
  88. Leukotriene-Receptor Expression on Nasal Mucosal Inflammatory Cells in Aspirin-Sensitive Rhinosinusitis
  89. Effect of fluticasone on the elastase:antielastase profile of the normal lung
  90. Glucocorticoid-resistant asthma
  91. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients
  92. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients
  93. Monocytes and macrophages - friend or foe?
  94. An annexin 1 (ANXA1)‐derived peptide inhibits prototype antigen‐driven human T cell Th1 and Th2 responses in vitro
  95. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein
  96. Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma
  97. Allergen-induced Proliferation and Interleukin-5 Production by Bronchoalveolar Lavage and Blood T Cells after Segmental Allergen Challenge
  98. IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis
  99. Relationship between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma
  100. IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expression
  101. IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: Relationship to expression of allergic disease
  102. Secretion of the eosinophil‐active cytokines interleukin‐5, granulocyte/macrophage colonystimulating factor and interleukin‐3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopics asthmatics, and atopic and nonatopic con...
  103. Mechanism of glucocorticoid action in asthma: too little, too late